gexpbas
assay
recent
develop
simultan
detect
multipl
pathogen
far
applic
gexp
assay
test
larger
clinic
sampl
hardli
report
communityacquir
pneumonia
cap
lead
caus
death
children
worldwid
substanti
proport
childhood
cap
caus
virus
rapid
accur
diagnosi
viru
infect
import
clinic
manag
cap
studi
explor
gexp
assay
simultan
detect
typessubtyp
virus
hospit
children
cap
total
nasopharyng
swab
prospect
collect
viral
nucleic
acid
extract
assay
use
viral
genom
dna
rna
templat
show
concentr
copi
dna
rna
target
virus
simultan
identifi
gexp
assay
fifteen
control
microorgan
contrast
fail
amplifi
assay
case
test
studi
viral
infect
patient
age
year
posit
rate
significantli
higher
patient
age
year
frequent
detect
viru
rsv
follow
hrv
adv
hbov
season
distribut
analysi
reveal
rsv
predomin
autumn
winter
spring
summer
rsv
frequent
identifi
similar
posit
percentag
one
hundr
twenti
randomlychosen
sampl
test
gexp
assay
reevalu
monortpcr
result
show
diagnosi
agreement
method
find
suggest
gexp
assay
could
valuabl
diagnost
tool
viru
infect
pediatr
patient
cap
commun
acquir
pneumonia
cap
children
potenti
seriou
often
result
hospit
lead
caus
respiratori
morbid
mortal
children
worldwid
etiolog
agent
cap
includ
bacteria
viru
bacteri
infect
appear
occur
mostli
older
children
viral
infect
preval
patient
age
year
virus
commonli
detect
children
cap
includ
respiratori
syncyti
viru
rsv
influenza
b
flu
b
parainfluenza
virus
piv
adenoviru
adv
human
rhinoviru
hrv
human
metapneumoviru
hpmv
etc
multiplex
revers
transcript
polymeras
chain
reaction
multiplex
rtpcr
combin
autom
capillari
electrophoresi
provid
platform
multitarget
genom
analysi
exampl
technolog
genomelab
gexp
genet
analysi
system
http
wwwbeckmancoultercomwsrportalbibliographi
develop
beckman
coulter
crea
ca
usa
principl
gexp
multiplex
amplif
assay
gexpbas
assay
divers
genom
sequenc
specif
amplifi
one
reaction
amplicon
differ
size
label
fluoresc
dye
separ
distinguish
autom
capillari
electrophoresi
multiplex
pcr
two
set
primer
use
one
set
forward
revers
primer
chimer
target
primer
contain
target
sequenc
univers
tag
set
forward
revers
primer
univers
primer
target
tag
fluoresc
label
use
significantli
higher
concentr
univers
primer
target
primer
reaction
system
target
sequenc
amplifi
chimer
primer
first
cycl
amplif
overtaken
univers
primer
eventu
gener
amplicon
contain
target
sequenc
fluorescencelabel
tag
use
gexpbas
assay
hu
et
al
abl
simultan
genotyp
nine
serotyp
enterovirus
zhang
et
al
detect
differenti
duck
virus
one
reaction
li
et
al
simultan
detect
multipl
human
respiratori
virus
nasopharyng
aspir
patient
pneumon
bronchopneumonia
far
applic
gexp
assay
test
larger
clinic
sampl
rare
report
studi
use
gexpbas
assay
simultan
detect
typessubtyp
virus
nasopharyng
specimen
collect
hospit
children
cap
sensit
specif
gexp
assay
determin
use
genom
nucleic
acid
rna
dna
variou
pathogen
templat
afterward
nasopharyng
swab
sampl
patient
cap
test
use
gexp
assay
view
commonli
identifi
newli
emerg
respiratori
virus
typessubtyp
virus
select
detect
target
target
panel
contain
follow
virus
flu
flu
b
influenza
rsv
hrv
adv
hmpv
human
bocaviru
hbov
coronaviru
coronaviru
sarsassoci
coronaviru
sar
influenza
influenza
nomenclatur
strain
base
neuraminidas
gene
genbank
access
number
influenza
season
influenza
influenza
align
conserv
genom
region
perform
pair
chimer
primer
design
target
viru
use
primer
premier
softwar
version
premier
biosoft
palo
alto
ca
primer
contain
genespecif
sequenc
univers
tag
pair
primer
target
univers
tag
use
forward
primer
label
fluoresc
dye
inform
primer
list
tabl
primer
synthes
sangon
biotech
shanghai
china
evalu
sensit
gexp
assay
nucleic
acid
target
virus
intern
control
dna
mix
make
templat
pool
target
pool
serial
dilut
obtain
dilut
contain
copi
dna
rna
multiplex
revers
transcript
rt
mix
revers
primer
rt
primer
target
virus
tabl
use
rt
perform
total
volum
contain
templat
pool
dilut
rt
buffer
rt
primer
mix
pmol
primer
unit
revers
transcriptas
rnase
inhibitor
unit
nucleasefre
water
rt
carri
follow
min
min
reaction
termin
incub
min
multiplex
pcr
mix
target
viru
primer
includ
forward
revers
mix
univers
primer
includ
forward
revers
use
multiplex
pcr
perform
follow
rt
product
mix
buffer
mgcl
mm
viral
primer
mix
pmol
primer
univers
primer
mix
pmol
primer
solut
x
taq
dna
polymeras
pcr
complet
thermocycl
veriti
thermal
cycler
appli
biosystem
china
beij
china
follow
step
step
min
step
step
repeat
cycl
follow
incub
min
amplifi
product
assess
use
genomelab
gexp
genet
analysi
system
beckman
coulter
evalu
specif
gexp
assay
nucleic
acid
control
microb
dna
mix
make
control
pool
control
pool
contain
ng
dna
rna
prepar
use
multiplex
rtpcr
analysi
describ
multiplex
rtpcr
product
analyz
genomelab
gexp
genet
analysi
system
follow
separ
buffer
ad
separ
plate
load
solut
ml
dna
size
multiplex
pcr
product
ad
reader
plate
cover
drop
miner
oil
analysi
perform
autom
manner
follow
establish
protocol
data
compil
gexp
system
softwar
provid
beckman
coulter
case
peak
low
cut
valu
use
positiveneg
judgement
test
repeat
confirm
consist
result
underlin
sequenc
univers
tag
sequenc
research
protocol
collect
use
clinic
data
approv
research
ethic
board
children
hospit
hebei
provinc
inform
written
consent
obtain
parent
particip
march
februari
total
nasopharyng
swab
specimen
collect
hospit
patient
diagnos
cap
within
hour
admiss
written
inform
consent
obtain
parent
particip
diagnosi
base
cap
diagnosi
manag
guidelin
establish
respiratori
societi
chines
medic
associ
nasopharyng
specimen
collect
transport
tube
contain
ml
dmem
medium
heatinactiv
fetal
calf
serum
iuml
penicillin
streptomycin
gibco
beij
china
sampl
store
day
viral
nucleic
acid
extract
two
hundr
nasopharyng
sampl
spike
ng
dna
rest
store
freezer
spike
sampl
use
total
viral
nucleic
acid
dna
rna
extract
use
easypur
viral
dnarna
kit
qsjbio
beij
china
accord
manufactur
instruct
final
viral
nucleic
acid
elut
nucleasefre
water
afterward
extract
nucleic
acid
analyz
gexpbas
assay
describ
posit
percentag
male
femal
patient
posit
percentag
among
differ
age
group
analyz
chisquar
test
use
spss
statist
packag
spss
inc
chicago
usa
p
consid
statist
signific
sensit
determin
use
serial
dilut
target
pool
shown
fig
concentr
virus
target
pool
detect
posit
flua
adv
hbov
hrv
sar
hmpv
test
posit
fig
adv
hbov
detect
posit
none
target
virus
amplifi
data
shown
specif
test
show
templat
control
pool
test
neg
fig
tini
peak
shown
panel
c
confirm
background
see
fig
nasopharyng
specimen
collect
hospit
children
male
femal
age
day
year
test
gexp
assay
demograph
patient
list
tabl
total
sampl
posit
least
one
viru
among
coinfect
observ
case
virus
discov
sampl
includ
rsv
hrv
adv
hbov
hmpv
flua
hcov
flub
among
rsv
detect
follow
hrv
adv
hbov
tabl
posit
rate
sampl
collect
male
femal
respect
differ
statist
signific
p
sampl
posit
compar
among
differ
age
group
ie
year
year
year
year
shown
tabl
posit
rate
group
year
year
significantli
higher
group
year
year
respect
season
distribut
analysi
reveal
rsv
predomin
autumn
winter
spring
summer
rsv
frequent
identifi
similar
posit
percentag
tabl
nucleic
acid
amplif
method
pcr
rtpcr
increasingli
explor
identif
pathogen
includ
viru
detect
infecti
respiratori
diseas
far
report
describ
use
techniqu
pathogen
detect
children
cap
determin
viral
etiolog
pediatr
cap
larger
clinic
seri
report
present
studi
appli
multiplex
rtpcr
togeth
autom
capillari
electrophoresi
name
gexpbas
assay
detect
viru
nasopharyng
specimen
hospit
children
cap
show
gexpbas
assay
high
sensit
specif
simultan
detect
multipl
virus
case
test
posit
viru
randomli
chose
sampl
test
gexpbas
assay
redo
monortpcr
found
diagnosi
agreement
method
data
shown
monortpcr
run
multiplex
reaction
use
chimer
univers
primer
singl
target
viru
test
posit
sampl
analysi
reveal
patient
younger
year
significantli
higher
viru
infect
rate
posit
rate
older
year
season
distribut
analysi
saw
rsv
predomin
autumn
winter
spring
summer
rsv
frequent
identifi
similar
posit
percentag
report
thu
far
describ
differ
assay
viru
detect
pediatr
cap
patient
chen
et
al
measur
antibodi
serum
sampl
collect
cap
children
found
posit
viru
sharp
contrast
find
other
discrep
like
attribut
antibodi
assay
target
type
virus
ie
influenza
b
parainfluenza
rsv
antibodi
assay
less
sensit
pcr
juven
et
al
explor
sever
method
ie
cell
cultur
viral
antigen
detect
antibodi
assay
rtpcr
determin
etiolog
cap
hospit
children
discov
patient
viral
infect
rsv
hrv
commonli
detect
cantai
test
type
virus
ie
rsv
adv
hmpv
hbov
coronaviru
flua
flub
hrv
piv
use
biplex
commerciallyavail
rtpcr
kit
children
cap
reveal
viral
infect
rhedin
et
al
employ
real
time
pcr
detect
viru
nasopharyng
aspir
children
age
year
cap
report
virus
detect
case
data
togeth
suggest
major
pediatr
cap
case
viru
infect
especi
younger
patient
knowledg
studi
first
use
gexpbas
assay
viru
detect
pediatr
cap
patient
assay
cover
broad
rang
viru
target
larg
size
sampl
test
due
autom
multiplex
procedur
gexpbas
assay
less
labori
monopcr
also
save
sampl
avoid
welltowel
pipet
error
present
studi
plasmid
dna
use
intern
control
monitor
pcr
revers
transcript
step
interestingli
publish
paper
describ
gexpbas
multiplex
assay
intern
control
employ
show
genom
rna
rna
virus
target
panel
success
amplifi
gexpbas
assay
fig
indic
revers
transcript
problem
howev
felt
rna
templat
use
intern
control
futur
work
anoth
limit
assay
highli
special
laboratori
equip
need
name
autom
capillari
electrophoresi
system
mani
clinic
laboratori
equip
outsourc
fragment
analysi
would
greatli
increas
turnaround
time
control
templat
pool
contain
ng
nucleic
acid
control
pathogen
copi
intern
control
use
reaction
repeat
shown
scaleddown
plot
tini
peak
identifi
background
product
similar
result
observ
independ
reaction
tif
conceptu
gl
